Raju Prasad Crispr Therapeutics Ag (CRSP) insider trading activity
Raju Prasad is Chief Financial Officer of CRISPR Therapeutics AG. Currently has a direct ownership of 16,767 shares of CRSP, which is worth approximately $570,581. The most recent transaction as insider was on Mar 21, 2025, when has been sold 2,197 shares (Common Shares) at a price of $41.23 per share, resulting in proceeds of $90,582. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
16.8K
158.91%
3M change
158.91%
12M change
Total Value Held
$570,581
Raju Prasad Transaction History
RP
Raju Prasad
Chief Financial Officer
Boston, MA